Wilmer Cutler Pickering Hale and Dorr advised Gemini, while Goodwin Procter advised Disc Medicine. Fried, Frank, Harris, Shriver & Jacobson acted as counsel to SVB Securities...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Houghton Mifflin Harcourt on the deal while Milbank represented Veritas Capital. Houghton Mifflin Harcourt Company (HMH), a learning technology...
You must be a Standard 1 Year member to access this content.
WilmerHale advised TMX on the deal. TMX Group Limited, an international financial services company, announced that it has closed an equity investment to acquire a minority...
You must be a Standard 1 Year member to access this content.
LeveL was represented in the transaction by the investment banking team at Rosenblatt Securities as its exclusive financial advisor and WilmerHale and Schulte Roth & Zabel...
You must be a Standard 1 Year member to access this content.
Morgan Lewis represented IQ Fiber in the transaction while Wilmer Cutler Pickering Hale and Dorr advised SDC Capital Partners. SDC Capital Partners, LLC (“SDC”) announced that...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Symphony on the deal while Wilmer Cutler Pickering Hale and Dorr represented Cloud9 Technologies. Symphony announced its acquisition of Cloud9 Technologies. Symphony is...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Verve Therapeutics on the deal. Verve Therapeutics (Nasdaq: VERV), a biotech company pioneering a new approach to the care of...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Amplitude Healthcare Corporation on the deal while Paul Hastings represented Jasper Therapeutics. Amplitude Healthcare Corporation (Nasdaq: AMHC), a special...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr LLP advised Sanofi on the deal. Sanofi, a global biopharmaceutical company focused on human health, announced its acquisition of Tidal...
You must be a Standard 1 Year member to access this content.
